[1]
S, M. and Rani A, P. 2018. SIMULTANEOUS REVERSE-PHASE ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF GRAZOPREVIR AND ELBASVIR. Asian Journal of Pharmaceutical and Clinical Research. 11, 4 (Apr. 2018), 100–104. DOI:https://doi.org/10.22159/ajpcr.2018.v11i4.21721.